The need for a correct oxygen-ozone autohemotherapy (O-AHT) in patients with mild to moderate COVID-19 pneumonia.
作者信息
Chirumbolo Salvatore, Pandolfi Sergio, Valdenassi Luigi, Bertossi Dario, Franzini Marianno
机构信息
Department of Neurosciences, Biomedicine and Movement Sciences, Strada Le Grazie 9, 37134, Verona, Italy.
Italian Society for Oxygen-Ozone Therapy (SIOOT), High School in Oxygen Ozone Therapy, University of Pavia, Pavia, Italy.
出版信息
Intern Emerg Med. 2021 Apr;16(3):793-794. doi: 10.1007/s11739-020-02592-w. Epub 2021 Jan 5.
Abstract
摘要
相似文献
1
The need for a correct oxygen-ozone autohemotherapy (O-AHT) in patients with mild to moderate COVID-19 pneumonia.轻度至中度新冠肺炎患者对正确的氧-臭氧自血疗法（O-AHT）的需求。
Intern Emerg Med. 2021 Apr;16(3):793-794. doi: 10.1007/s11739-020-02592-w. Epub 2021 Jan 5.
2
CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial.臭氧血液疗法治疗伴有呼吸衰竭的新型冠状病毒肺炎（CORMOR）患者：一项多中心前瞻性随机临床试验
Int Immunopharmacol. 2021 Sep;98:107874. doi: 10.1016/j.intimp.2021.107874. Epub 2021 Jun 12.
3
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.轻度至中度 COVID-19 肺炎患者的血液臭氧疗法：单中心经验。
Intern Emerg Med. 2021 Apr;16(3):669-675. doi: 10.1007/s11739-020-02542-6. Epub 2020 Nov 1.
4
Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed.采用臭氧自血疗法治疗新冠肺炎需要符合经验丰富、量身定制且标准化的方案才能取得成功。
J Med Virol. 2021 May;93(5):2580-2582. doi: 10.1002/jmv.26806. Epub 2021 Jan 27.
5
Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy.接受维持性肾脏替代治疗的终末期肾病患者，臭氧自血疗法对自然杀伤细胞活性无影响。
Int J Artif Organs. 2004 Sep;27(9):766-71. doi: 10.1177/039139880402700906.
6
Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients.新冠病毒感染后综合征（PASC）患者接受氧-臭氧自体血疗法治疗后的疲劳：100 例患者的初步结果。
Eur Rev Med Pharmacol Sci. 2021 Sep;25(18):5871-5875. doi: 10.26355/eurrev_202109_26809.
7
Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.维持性血液透析患者的臭氧自血疗法：对血脂谱和内皮的影响
Artif Organs. 2004 Feb;28(2):234-7. doi: 10.1111/j.1525-1594.2003.47211.x.
8
Oxygen-ozone (O-O) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.用于 COVID-19 患者的氧气-臭氧（O-O）免疫疗法。初步报告的证据。
Int Immunopharmacol. 2020 Nov;88:106879. doi: 10.1016/j.intimp.2020.106879. Epub 2020 Aug 8.
9
Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19.氧-臭氧（O2-O3）疗法有助于治疗新型冠状病毒COVID-19的潜在机制。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4059-4061. doi: 10.26355/eurrev_202004_20976.
10
Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.臭氧氧气疗法作为 SARS-CoV-2 感染急救治疗的辅助手段：一项临床研究。
J Biol Regul Homeost Agents. 2020 May-Jun;34(3):757-766. doi: 10.23812/20-250-E-56.
引用本文的文献
1
Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2.臭氧疗法在新兴病毒性疾病中的作用机制：参考SARS-CoV-2的免疫调节作用和治疗优势
Front Microbiol. 2022 Apr 21;13:871645. doi: 10.3389/fmicb.2022.871645. eCollection 2022.
2
Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.关于臭氧在抗新冠病毒医学治疗中作用机制的见解。
Int Immunopharmacol. 2021 Jul;96:107777. doi: 10.1016/j.intimp.2021.107777. Epub 2021 May 11.
本文引用的文献
1
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.轻度至中度 COVID-19 肺炎患者的血液臭氧疗法：单中心经验。
Intern Emerg Med. 2021 Apr;16(3):669-675. doi: 10.1007/s11739-020-02542-6. Epub 2020 Nov 1.
2
Oxygen-ozone (O-O) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.用于 COVID-19 患者的氧气-臭氧（O-O）免疫疗法。初步报告的证据。
Int Immunopharmacol. 2020 Nov;88:106879. doi: 10.1016/j.intimp.2020.106879. Epub 2020 Aug 8.
Zotero 插件